HR 4396 · 114th Congress · Health

Heroin and Prescription Drug Abuse Prevention and Reduction Act

Introduced 2016-01-28· Sponsored by Rep. Pallone, Frank, Jr. [D-NJ-6]· House

Bill Progress

Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the Subcommittee on Health, Employment, Labor, and Pensions.(2016-03-23)

Plain Language Summary

[AI summary unavailable — showing source text] Heroin and Prescription Drug Abuse Prevention and Reduction Act This bill amends the Controlled Substances Act to revise requirements for and limitations on practitioners who dispense narcotic drugs for maintenance or detoxification treatment. The Department of Health and Human Services (HHS) must establish grant programs to: (1) encourage prescribing and purchase of opioid overdose reversal drugs (e.g., naloxone), and (2) develop prescribing guidelines for such drugs. (Opioids are drugs with effects similar to opium, such as heroin or certain pain medications.) The Centers for Disease Control and Prevention must provide support to improve drug overdose surveillance and reporting capabilities. HHS may support syringe exchange programs. The Substance Abuse and Mental Health Services Administration must provide support to: (1) reduce drug overdose deaths; and (2) develop, expand, and enhance substance use recovery support services. This bill amends the Public Health Service Act to extend residential treatment programs for pregnant and postpartum women. The Center for Substance Abuse Treatment must: (1) carry out a pilot program to support services for pregnant and postpartum women wi…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (20)

20 Democrats